G. Oliveira-Duarte

BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution

C. D. de Souza, M. Delamain, B. F. Ribeiro, 2015, Acta Haematologica.

Normal variation of bone marrow B‐cell precursors according to age – reference ranges for studies in myelodysplastic syndromes in Brazil

K. Metze, M. Santos-Silva, A. Longhini, 2018, Cytometry. Part B, Clinical cytometry.

Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience

C. D. de Souza, M. Delamain, B. F. Ribeiro, 2015, Clinics.

Brazilian experience using high-dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for relapsed or refractory Hodgkin lymphoma.

S. Brandalise, C. D. de Souza, M. Nucci, 2009, Clinical Lymphoma & Myeloma.

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

C. D. de Souza, A. Vigorito, D. M. Albuquerque, 2013, BMC Infectious Diseases.

Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas

C. D. de Souza, M. Nucci, M. Delamain, 2009, Revista brasileira de hematologia e hemoterapia.

Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression‐free survival in multiple myeloma

E. Braggio, E. Rego, V. Hungria, 2012, American journal of hematology.